共 77 条
[1]
Schlendorf KH(2018)Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapies J Heart Lung Transplant 37 763-769
[2]
Zalawadiya S(1993)24th Bethesda conference: cardiac transplantation. Task Force 3: recipient guidelines/prioritization J Am Coll Cardiol 22 21-31
[3]
Shah AS(2011)Improved survival in heart transplant recipients in the United States: racial differences in era effect Circ Heart Fail. 4 153-160
[4]
Wigger M(2012)Heart allocation in the United States: intended and unintended consequences Circ Heart Fail 5 140-143
[5]
Chung CY(2016)Major advantages and critical challenge for the proposed United States heart allocation system J Heart Lung Transplant 35 547-549
[6]
Smith S(1999)Administrative developments: DHHS issues organ allocation final rule J Law Med Ethics 27 380-382
[7]
Danter M(2020)An early investigation of outcomes with the new 2018 donor heart allocation system in the United States J Heart Lung Transplant 39 1-4
[8]
Choi CW(2020)The Society of Thoracic Surgeons Intermacs 2019 annual report: the changing landscape of devices and indications Ann Thorac Surg 109 649-660
[9]
Keebler ME(2020)Update to an early investigation of outcomes with the new 2018 donor heart allocation system in the United States J Heart Lung Transplant 39 725-726
[10]
Brinkley DM(2020)Outcomes of the first 1300 adult heart transplants in the United States after the allocation policy change Circulation. 141 1662-1664